Cidara Therapeutics Inc (NASDAQ:CDTX) Reported Basic Consolidated EPS Of $-3.2453 For Period Ended 2015-12-31

0

The annual basic consolidated EPS for Cidara Therapeutics Inc (NASDAQ:CDTX) for the period ended 2015-12-31 was $-3.2453. On quarterly basis, the basic consolidated EPS reading for the quarter ended 2015-12-31 was $-3.2453.

EPS from continuing operations

Coming to basic EPS from continuing operations, Cidara Therapeutics Inc (NASDAQ:CDTX) reported $-3.2453 for the annual period ended 2015-12-31. Quarterly basic EPS from continuing operations for the three-month period ended 2015-12-31 stood at $-3.2453.

EPS contribution from parent

For the annual period ended 2015-12-31, Cidara Therapeutics Inc (NASDAQ:CDTX) received basic EPS of $-3.2453 from its parent company. On quarterly basis, basic EPS contribution from the parent company for the period ended 2015-12-31 was $-3.2453.

Basic net EPS

For the annual period ended 2015-12-31, Cidara Therapeutics Inc (NASDAQ:CDTX) reported basic net EPS of $-3.25. On quarterly basis, the company’s basic net EPS for the three-month period ended 2015-12-31 stood at $-3.25.

Consolidated diluted EPS

The annual consolidated diluted EPS reading for the period ended 2015-12-31 stood at $-3.2453. For the quarter ended 2015-12-31, consolidated diluted EPS was $-3.2453.

Basic diluted EPS

On annual basis, diluted EPS reading from continuing operation was $-3.2453 for the period ended 2015-12-31. Diluted EPS from continuing operations for the quarter ended 2015-12-31 was $-3.2453.

Net diluted EPS

Net diluted EPS reading for the annual period ended 2015-12-31 was $-3.25. For the quarterly period ended 2015-12-31, net diluted EPS was $-3.25.

Diluted EPS from parent

From the parent company, Cidara Therapeutics Inc (NASDAQ:CDTX) received diluted EPS of $-3.2453 for the annual period ended 2015-12-31. On quarterly basis, diluted EPS contribution from the parent for the quarter ended 2015-12-31 was $-3.2453.

Cidara Therapeutics Inc (NASDAQ:CDTX) posted net basic EPS reading of $-3.25 for the annual period ended 2015-12-31. For the quarter, basic net EPS of $-3.25 was for the quarter ended 2015-12-31.

Net diluted EPS for Cidara Therapeutics Inc (NASDAQ:CDTX) for the annual period ended 2015-12-31 was $-3.25. The company also reported net diluted EPS reading of $-3.25 for the quarter ended 2015-12-31.

The annual average basic shares outstanding for the period ended 2015-12-31 is 9.92 while for the quarter ended 2015-12-31 is 9.92.

The diluted shares outstanding for the fiscal year ended is 2015-12-31 is 9.92 while for the quarter ended 2015-12-31 is 9.92.

1 Chart Pattern Every Investor Should Know

This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...

Click Here to See This Now.

(Visited 17 times, 1 visits today)